Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.01% of BTTX shares are held by financial institutions. STRIVE FINANCIAL GROUP ,LLC is the top corporate investor, holding 5K shares valued at $1.00. A 0.01% stake in Better Therapeutics, Inc. is owned by the company. ANCORA ADVISORS, LLC owns 3K shares valued at $1.00, which translates its holding of 0.01% of the stake in the company.
Among the BTTX insiders holding of 45.44% of the stake in company, PERRY DAVID P, Executive Chairman, holds the largest shares of 13.03M. MOUNTAIN CREST CAPITAL LLC, 10 percent owner, is the second largest BTTX insider with ownership of 1.37M shares. LIU SUYING, Chief Executive Officer, stands third with possession of 1.37M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| PERRY DAVID P | Executive Chairman | 13.03M |
| MOUNTAIN CREST CAPITAL LLC | 10 percent owner | 1.37M |
| LIU SUYING | Chief Executive Officer | 1.37M |
| LIU DONG | Chief Financial Officer | 1.37M |
| PARKER GEOFFREY M. | director | 1.03M |
| ARMANINO ANDREW J. | director | 728.37K |
| KARBE FRANK | Chief Executive Officer | 429.43K |
| BERMAN MARK A. | Chief Medical Officer | 388.19K |
| HEINEN MARK | See Remarks | 70K |
| GRANGER ELDER | director | 35.85K |
| LAVIZZO-MOUREY RISA J | director | 10K |
| KEVIN APPELBAUM, OR HIS SUCCESSOR(S), AS TRUSTEE OF THE KEVIN APPELBAUM REVOCABLE TRUST UNDER REVOCABLE TRUST DECLARATION DATED 5/16/2020, AS AMENDED | | 6.25K |
| APPELBAUM KEVIN J | Chief Executive Officer | 3.75K |
